Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: What is the role of surgery?

Pediatric Surgery International

Volumn 18, Issue 5-6, 2002, Pages 289-294

  Hase, Takanobu ^a   Ohta, Shigeru ^a   Tani, Tohru ^a   Mizukuro, Tomoyuki ^a   Mekata, Eizi ^a   Naitoh, Hiroyuki ^a   Shimadera, Shin'ichi ^a   Fujino, Syouzou ^a   Taga, Takashi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Mass screening; Neuroblastoma; Neuron specific enolase; Role of surgery N myc

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ENOLASE; HOMOVANILLIC ACID; LACTATE DEHYDROGENASE; VANILMANDELIC ACID; VINCRISTINE; TUMOR MARKER;

ADRENAL GLAND; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; INFANT; JAPAN; MALE; MASS SCREENING; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; ONCOGENE C MYB; OUTCOMES RESEARCH; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROPERITONEUM; RETROSPECTIVE STUDY; SOUTHERN BLOTTING; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; THORAX; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; URINE LEVEL; ADRENAL TUMOR; MORTALITY; PATHOLOGY; PROGNOSIS; RETROPERITONEAL TUMOR; TREATMENT OUTCOME; URINE;

ADRENAL GLAND NEOPLASMS; FEMALE; HOMOVANILLIC ACID; HUMANS; INFANT; JAPAN; MALE; MASS SCREENING; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VANILMANDELIC ACID;

EID: 0036730698     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003830100701     Document Type: Article

References (31)

1. Sawada T, Todo S, Fujita K, Iino S, Imasyuku S, Kusunoki T (1982) Mass screening for neuroblastoma in infancy. Am J Dis Child 136: 710-712
2. Nishi M, Miyake H, Takeda T, Shimada M (1987) Effects of the mass screening of neuroblastoma in Sapporo City. Cancer 60: 433-436
3. Tuchman M, Lemieux B, Auray-Blais C, et al (1990) Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project. Pediatrics 86: 765-773
4. Parker L, Craft AW, Dale G, Bell S, Cole M, McGill AC, Seviour JA, Smith J (1992) Screening for neuroblastoma in the north of England. Br Med J 305: 1260-1263
5. Mathieu P, Frappaz D, Chauvin F, Combaret V, Vercherat M, Brunat-Mentigny M, David L, Esteve J, Favrot M, Fouillat V, Greffe J, Lasset C, Renaud P, Philip T (1996) 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary oservations. Early Hum Dev 46: 177-196
6. Kerbl R, Starz I, Urban C (1991) Neuroblastoma for Austria by use of EIA-methods. Presented at the II International Symposium on Neuroblastoma Screening, Minneapolis, 22-24, May
7. Tuchman M, Fisher EJ, Heisel MA, Woods WG (1989) Feasibility study for neuroblastoma screening in the United States. Med Pediatr Oncol 17: 258-264
8. Etman R, Shilling FH, Dohrmann S, et al (1993) Two years experience of the German pilot study for the early detection of neuroblastoma. Presented at the III International Symposium on Neuroblastoma Screening, Kyoto, Japan
9. Tuchman M, Woods WG (1992) Introduction: neuroblastoma screeing. Laboratory, clinical, and epidemiological aspects. Am J Pediatr Hematol Oncol 14: 95-96
10. Murphy SB, Cohn SL, Craft AW, Woods WG, Sawada T, Castleberry RP, Levy HL, Prorock PC, Hammond GD (1991) Do children benefit from mass screening for neuroblastoma? Lancet 337: 344-346
11. Woods WG, Tuchman M, Robison LL, Bernstein M, Leclerc JM, Brisson LC, Brossard J, Hill G, Shuster J, Leupker R, Byrne T, Weitzman S, Bunin G, Lemieux B (1996) A population-based study of the usefulness of screening for neuroblastoma. Lancet 348: 1682-1687
12. Treuner J, Schilling FH (1995) Neuroblastoma mass screening: the arguements for and against. Eur J Cancer 31A: 565-568
13. Schilling FH, Erttmann R, Ambros PF, Strehl S, Christiansen H, Kovar H, Kabisch H, Treuner J (1994) Screening for neuroblastoma. Lancet 344: 1157-1158
14. Evans AE, D'Angio GJ, Randolf JA (1971) A proposed staging for children with neuroblastoma: Children's Cancer Study Group A. Cancer 27: 374-378
15. Sawada T, Shikata T, Matsumura T, Kawakatsu H, Sugimoto T, and NB Screening Study Group (1994) Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. Neuroblastoma Res 4: 371-375
16. Chamberlain J (1994) Screening for neuroblastoma; a review of the evidence. J Med Screen 10: 30-39
17. Sawada T (1992) Past and future of neuroblastoma screening in Japan. Am J Pediatr Hematol Oncol 14: 320-326
18. Nishi M, Miyake H, Takeda T, Hanai J, Kikuchi Y, Takasuki N (1997) Mass screening for neuroblastoma and mortality in birth cohorts. Int J Cancer 71: 552-555
19. Woods WG, Tuchman M, Robison LL, Bernstein M, Leclerc JM, Brisson LC, Brossard J, Hill G, Shuster J, Leupker R, Byrne T, Weitzman S, Bunin G, Lemieux B, Brodeur GM (1997) Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable advanced stage disease in older children. Eur J Cancer 33: 106-112
20. Zelter PM, Marangos PJ, Evans AE, Schneider SL (1986) Serum neuron-specific enolase in children with neuroblastoma. Cancer 57: 1230-1234
21. Castleberry RP (1998) Risk groups in loco-regional neuroblastoma. Med Pediatr Oncol 31: 253
22. Brodeur GM, Seeger RC, Schwab M, Varmas HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121-1124
23. Gansler T, Chatten J, Varello M, Bunin GR, Atkinson B (1986) Flow cytemetric DNA analysis of neuroblastoma: correlation with histology and clinical outcome. Cancer 58: 2453-2458
24. Look AT, Hayes FA, Shuster JJ, et al (1991) Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: Pediatric Oncologic Group study. J Clin Oncol 9: 581-591
25. Caron H, van Sluis P, de Kraker J, Bokkerink J, Eager M, Lavreys G (1996) Alleic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 334: 225-230
26. Nakagawara A, Arima-Nakagawara M,Scavartda NJ, Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the trk gene and favorable outcome in human neuroblastoma. N Eng J Med 328: 847-853
27. Norris MD, Bordow SB, Marshall GM, et al (1996) Expression of the gene for multidrug-resistance associated protein and outcome in patients with neuroblastoma. N Eng J Med 334: 231-238
28. Brodeur GM (1995) Molecular basis for heterogenety in human neuroblastomas. Eur J Cancer 31A: 505-510
29. Yamamoto H, Yoshida M, Sera Y (1996) Laparoscopic surgery for neuroblastoma identified by mass screening. J Pediatr Surg 31: 385-388
30. Nakajima K, Fukuzawa M, Fukui Y, Komoto Y, Usui N, Iiboshi Y, Nose K, Okada A (1997) Laparoscopic resection of mass-screened adrenal neuroblastoma in an 8-month-old infant. Surg Laparosc Endosc 7: 498-500
31. Ricardi R, Lasorella A, Mastrangelo R (1998) Principles of cancer chemotherapy in children. Oxford University Press, New York, pp 44-59